Concourse Financial Group Securities’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 10628 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 10908 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 10818 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 10665 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 10687 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 10816 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 10858 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 10936 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10556 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10559 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10374 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 10157 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9914 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9471 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8800 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8293 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7794 |
|